Specifically, SOX9 has been found to influence self-renewal, invasion, and proliferation in lung (27), hepatocellular (28), breast (29), prostate (30), skin (31), and pancreatic cancers (32). Here, SOX9 is linked to familial pancreatic carcinoma.